Bayban’s Stryker SYK Stock Holding History

Bayban’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.61K	Sell	21 -9	-30%	-$2.84K	0.01%	434
2026 Q1	$9.86K	Sell	30 -300	-91%	-$108K	0.01%	413
2025 Q4	$116K	Buy	+330	New	+$120K	0.1%	150

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bayban's SYK Position: Q2 2026 in Review

Bayban reduced its Stryker (SYK) stake by 30% in Q2 2026, selling an estimated $2.84K and leaving 21 shares worth $6.61K. The position accounts for 0.01% of the portfolio, ranked #434.

Bayban first reported a position in SYK in Q4 2025 and has held it in 3 quarters since. The position peaked at $116K in Q4 2025. 2,156 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

Bayban held 21 shares of Stryker worth $6.61K as of Q2 2026.
Bayban sold 9 Stryker shares in Q2 2026, an estimated $2.84K.
Stryker made up 0.01% of Bayban's portfolio in Q2 2026, its #434 holding.
Bayban first reported a position in Stryker in Q4 2025 and has held it in 3 quarters since.
Bayban's Stryker position peaked at $116K in Q4 2025.
2,156 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.